Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trials Post author: Post published: December 5, 2023 Post category:uncategorized The safety, efficacy, and immunogenicity of a mRNA-based vaccine. You Might Also Like NIH’s continued investment fuels TMJ pain research February 27, 2026 Small molecule discovery offers hope for treatment of Angelman syndrome July 8, 2024 Why AI tools need clearer guardrails in high-stakes health research May 19, 2026